Payer and Specialty Pharmacy Forum: Clinical Updates and Outcomes Data for PCSK9 Inhibitors

https://www.pharmacytimes.org/on-demand/an-american-journal-of-managed-care-payer-and-specialty-pharmacy-forum-clinical-updates-and-outcomes-data-for-pcsk9-inhibitors

Related Videos

Related Content

Advertisement

October 12th 2024

Doing Things Differently: Wilfong Moves to Thyme Care

Mary Caffrey

Lalan Wilfong, MD, a 20-year medical oncologist with Texas Oncology, is senior vice president, value-based care, Thyme Care.

October 3rd 2024

Dr Rick Chapman Discusses Key Insights From the Center’s Rare Disease Project

Brooke McCormick

On this episode of Managed Care Cast, we're talking with the chief science officer of the Center for Innovation & Value Research about key insights from its Rare Disease project.

October 12th 2024

Early Biomarker Testing Key for Perioperative NSCLC Success

Rose McNulty Maggie L. Shaw

Ticiana Leal, MD, Winship Cancer Institutes, explains the importance of biomarker testing and multidisciplinary conversations while caring for patients with early-stage non–small cell lung cancer (NSCLC).

September 30th 2024

Sustaining Compassionate Trauma Care Across Communities

Maggie L. Shaw

September is National Recovery Month, and we are bringing you another limited-edition month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In our final episode, we speak with Lyndra Bills, MD, and Shari Hutchison, MS.

October 11th 2024

Delays in Myeloma Oral Therapy Linked to Race, Age

Maggie L. Shaw

Outcomes of interest in this study were time from diagnosis to initial prescription fill for an oral multiple myeloma (MM) medication and time from initial diagnosis to receipt of any treatment for MM.

October 11th 2024

FDA Approves Marstacimab, First Weekly Sub-Q Option for Hemophilia B

Mary Caffrey

Related Content

Advertisement

October 12th 2024

Doing Things Differently: Wilfong Moves to Thyme Care

Mary Caffrey

Lalan Wilfong, MD, a 20-year medical oncologist with Texas Oncology, is senior vice president, value-based care, Thyme Care.

October 3rd 2024

Dr Rick Chapman Discusses Key Insights From the Center’s Rare Disease Project

Brooke McCormick

On this episode of Managed Care Cast, we're talking with the chief science officer of the Center for Innovation & Value Research about key insights from its Rare Disease project.

October 12th 2024

Early Biomarker Testing Key for Perioperative NSCLC Success

Rose McNulty Maggie L. Shaw

Ticiana Leal, MD, Winship Cancer Institutes, explains the importance of biomarker testing and multidisciplinary conversations while caring for patients with early-stage non–small cell lung cancer (NSCLC).

September 30th 2024

Sustaining Compassionate Trauma Care Across Communities

Maggie L. Shaw

September is National Recovery Month, and we are bringing you another limited-edition month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In our final episode, we speak with Lyndra Bills, MD, and Shari Hutchison, MS.

October 11th 2024

Delays in Myeloma Oral Therapy Linked to Race, Age

Maggie L. Shaw

Outcomes of interest in this study were time from diagnosis to initial prescription fill for an oral multiple myeloma (MM) medication and time from initial diagnosis to receipt of any treatment for MM.

October 11th 2024

FDA Approves Marstacimab, First Weekly Sub-Q Option for Hemophilia B

Mary Caffrey